A better view of the choices still available
A medicines availability problem reaches beyond a stock figure. It changes the work of pharmacy teams, the questions coming from patients and clinicians, and the decisions organisations must coordinate under pressure.
NEUVIOR’s supply-resilience research direction asks how medicines intelligence could make those organisational choices easier to examine. We begin with a recurring decision, the responsible team and the information needed to support it. The ambition is useful preparation and coordination around a clearly defined supply problem.
In the conversation.
NEUVIOR and our founder’s perspectives have appeared across science, business and technology publications.
Reporting, commentary, letters and podcast appearances | Read each feature for its format and source.
Start with the decision under pressure
A community pharmacy may need to understand an unresolved availability issue and coordinate the next enquiry. A provider team may be examining a disruption across services. A supplier may need to communicate changing conditions to several organisations.
These are different tasks. Define who can act, what authority they have and which options are actually available. This prevents an attractive national picture from being mistaken for a workable local answer. It also identifies where professional or supplier input is essential before a course of action can be considered.
Availability needs context
A recorded quantity does not establish that medicine is usable in the place and period it is needed. Timing, presentation, practical access, replenishment and local requirements can alter the meaning of an apparent supply position.
A useful evidence case states the information’s date, scope and limits. A public shortage notice, a supplier update and an authorised local operational record offer different kinds of evidence. The first research task is to establish whether those sources can support the particular decision, and where missing or delayed information would make the comparison unreliable.
Look beyond the next immediate action
A choice that appears sensible today can change what remains possible tomorrow. Waiting for information, coordinating an enquiry or introducing a local contingency each has consequences for workload and available options.
Our interest is in helping professional teams examine those consequences over an agreed period. Make the assumptions about demand, timing and supply explicit, and identify which change in circumstances would require another review. This keeps the discussion connected to operational reality rather than present a general prediction as certainty about what will be available.
Account for the work scarcity creates
Supply disruption consumes attention as well as stock. Teams investigate, clarify, communicate and revisit decisions when conditions change. That burden deserves a place in the evaluation.
The 2024 ASHP hospital survey reported up to 66 pharmacy staff hours a week spent mitigating drug shortages, varying with hospital size. Published in June 2025, the findings came from 250 hospital respondents with weighted national estimates. This US observation shows why workload matters; it is not a burden estimate for every pharmacy or a PHARMORIS time-saving claim.
Supply pressure becomes local work.
A production line is one part of a much wider medicines journey. A local supply question also depends on the product, date, permitted alternatives and the professional responsibility around the next action.
Keep the constraint visible alongside the work needed to respond to it. Public information can provide context without becoming a live view of every pharmacy’s stock.
Film source and contextStock manufacturing context. Not NEUVIOR equipment, a customer line, a PHARMORIS-ECO installation or proof of GMP status.
A public decision brief | An illustrative example
Open the question.
Inspect the reasoning.
Choose a business question, then look beneath its claim. See what a public source supports, what depends on the local setting and what a useful next step could be.
A distribution, quality or operations team examining the completeness of a temperature-controlled handoff record.
Can the next responsible person see the whole handoff?
Before an exception can be assessed, the responsible people need a coherent record: the item, the relevant conditions, the journey and the evidence still missing.
A proposition to investigate
Make the evidence easier to hand over.
A structured evidence brief could help a team identify what is present, what conflicts and what must be requested. The proposed value is a clearer handoff for authorised review. It does not decide whether a medicine can be used, released, returned or destroyed, and it supplies no treatment recommendation.
This is a constructed records question, not a live temperature event or disposition instruction.
What the next brief would contain
A decision someone
can commission.
- The decision
- Whether the handoff process needs a structured evidence request or evaluation.
- The comparator
- The organisation's current records and authorised handoff procedure.
- The evidence
- Applicable requirements, custody, logger details, time alignment, completeness and reviewer questions.
- Stop or redesign
- Stop if responsibility is unclear, evidence cannot be verified or the activity drifts into unauthorised disposition.
Constructed public example | Not PHARMORIS-generated software output or a measured customer result.
Keep this example briefKeep professional responsibility clear
A supply-related option can raise clinical, commercial and practical questions. Qualified people and the relevant organisations retain responsibility for those decisions. The review needs to distinguish information about a supply issue from authority to change treatment or move medicines.
A proposed evaluation should therefore identify the decision-maker, necessary approvals and route for unresolved questions. For community, hospital, online and supplier settings, the useful proposition may differ substantially. Scope should follow the real decision and the information that can appropriately be used, rather than promise one universal supply solution.
Test where the information can carry the decision
A credible first study can examine an agreed historical or illustrative scenario before any operational use is considered. Start with a meaningful existing approach and ask whether a different way of preparing or reviewing the case adds useful information.
Include difficult conditions: missing sources, late updates, unusual demand and an option that turns out to be unavailable. Examine whether users understand the uncertainty and whether the work fits their responsibilities. The result should establish a more precise next research question, rather than imply a live stock-allocation or replenishment service.
Bring a supply question with an accountable team
We welcome pharmacy, medicines supply, provider and industry teams with a recurring organisational decision to examine. Tell us the task, the current process and which information is genuinely available to the people responsible.
Those details help identify a useful evaluation boundary and the professional expertise needed to test whether medicines intelligence can add value.